Contract 75A50124C00001
Ppd Development Lp · Department Of Health And Human Services · August 30, 2024
Ppd Development Lp was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 30, 2024 for $117.40 million (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Wilmington, NC. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses cost-plus contract pricing. The most recent modification was on November 12, 2025. If all options are exercised, the contract could reach $222.13 million.
Contract details
- PIID
- 75A50124C00001
- Award type
- Definitive Contract
- Pricing
- Cost Plus Incentive Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Wilmington, NC
- First action
- August 30, 2024
- Latest action
- November 12, 2025
Description
BARDA WILL IMPLEMENT A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER PHASE 2 TRIAL IN THE US TO EVALUATE THE SAFETY AND EFFICACY OF NOVEL HOST-DIRECTED THERAPEUTIC CANDIDATES IN HOSPITALIZED ADULTS WITH ARDS.
Modification timeline
-
November 12, 2025Mod P00003 · Other Administrative Action$117.40M
-
July 11, 2025Mod P00002 · Other Administrative Action$117.40M
-
August 30, 2024Mod P00001 · Other Administrative Action$117.40M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124C00001?
Contract 75A50124C00001 is a federal contract awarded to Ppd Development Lp by Department Of Health And Human Services on August 30, 2024 for $117.40 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 75A50124C00001?
Ppd Development Lp won contract 75A50124C00001 from Department Of Health And Human Services.
How much is contract 75A50124C00001 worth?
Contract 75A50124C00001 has obligated $0 to date but carries a potential ceiling of $222.13 million if fully funded and all options are exercised.